{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:07:01Z","timestamp":1791180421156,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejinme.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.ejim.2013.03.014","type":"journal-article","created":{"date-parts":[[2013,4,18]],"date-time":"2013-04-18T15:34:49Z","timestamp":1366299289000},"page":"617-623","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"title":["Outpatient parenteral antibiotic therapy: Principles and practice"],"prefix":"10.1016","volume":"24","author":[{"given":"R.A.","family":"Seaton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.A.","family":"Barr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2013.03.014_bb0005","series-title":"Scottish national point prevalence survey of healthcare associated infection and antimicrobial prescribing 2011","author":"Health Protection Scotland","year":"2012"},{"key":"10.1016\/j.ejim.2013.03.014_bb0010","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.ijantimicag.2006.10.020","article-title":"Point prevalence survey of antibiotic use in Scottish Hospitals; evaluation of the Glasgow Antimicrobial Audit Tool (GAAT)","volume":"29","author":"Seaton","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ejim.2013.03.014_bb0015","series-title":"Antimicrobial stewardship: \u201cStart smart \u2014 then focus\u201d","article-title":"Department of health advisory committee on antimicrobial resistance and healthcare associated infection","year":"2011"},{"key":"10.1016\/j.ejim.2013.03.014_bb0020","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1542\/peds.54.3.358","article-title":"Outpatient intravenous medications in the management of cystic fibrosis","volume":"54","author":"Rucker","year":"1974","journal-title":"Pediatrics"},{"key":"10.1016\/j.ejim.2013.03.014_bb0025","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/BF01690748","article-title":"Experience with a physician-directed, clinic-based program for outpatient parenteral antibiotic therapy in the USA","volume":"14","author":"Tice","year":"1995","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ejim.2013.03.014_bb0030","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2165\/00019053-200018050-00004","article-title":"Cost analysis of an adult outpatient parenteral antibiotic therapy (OPAT) programme. A Canadian teaching hospital and Ministry of Health perspective","volume":"18","author":"Wai","year":"2000","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.ejim.2013.03.014_bb0035","doi-asserted-by":"crossref","first-page":"440","DOI":"10.5694\/j.1326-5377.2002.tb04450.x","article-title":"Hospital-in-the-home treatment of infectious diseases","volume":"176","author":"Howden","year":"2002","journal-title":"Med J Aust"},{"key":"10.1016\/j.ejim.2013.03.014_bb0040","first-page":"U1020","article-title":"Outpatient Parenteral Antimicrobial Therapy (OPAT): a review of experience at Auckland Hospital","volume":"117","author":"Upton","year":"2004","journal-title":"N Z Med J"},{"key":"10.1016\/j.ejim.2013.03.014_bb0045","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ijantimicag.2006.08.018","article-title":"Outpatient parenteral antibiotic therapy in Singapore","volume":"28","author":"Fisher","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ejim.2013.03.014_bb0050","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1179\/joc.2007.19.4.417","article-title":"Outpatient parenteral antibiotic therapy for bone and joint infections: an italian multicenter study","volume":"19","author":"Esposito","year":"2007","journal-title":"J Chemother"},{"key":"10.1016\/j.ejim.2013.03.014_bb0055","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/jac\/dkm210","article-title":"Outpatient parenteral antimicrobial therapy (OPAT): is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13years","volume":"60","author":"Matthews","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ejim.2013.03.014_bb0060","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1093\/jac\/dkp343","article-title":"Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective","volume":"64","author":"Chapman","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ejim.2013.03.014_bb0065","first-page":"332","article-title":"Out-patient and home-parenteral antibiotic therapy (OHPAT): evaluation of the impact of one year's experience in Tayside","volume":"57","author":"Nathwani","year":"1999","journal-title":"Health Bull (Edinb)"},{"key":"10.1016\/j.ejim.2013.03.014_bb0070","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1093\/jac\/dkp212","article-title":"Establishment of an outpatient and home parenteral antimicrobial therapy service at a London teaching hospital: a case series","volume":"64","author":"Hitchcock","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ejim.2013.03.014_bb0075","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1086\/420939","article-title":"Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines","volume":"38","author":"Tice","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ejim.2013.03.014_bb0080","doi-asserted-by":"crossref","first-page":"156","DOI":"10.5694\/j.1326-5377.1999.tb127711.x","article-title":"Hospital in the home: a randomised controlled trial","volume":"170","author":"Caplan","year":"1999","journal-title":"Med J Aust"},{"key":"10.1016\/j.ejim.2013.03.014_bb0085","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1136\/bmj.38309.447975.EB","article-title":"Randomised controlled trial of intravenous antibiotic treatment for cellulitis at home compared with hospital","volume":"330","author":"Corwin","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.ejim.2013.03.014_bb0090","first-page":"CD007491","article-title":"Admission avoidance hospital at home","author":"Shepperd","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejim.2013.03.014_bb0095","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/jac\/dkp051","article-title":"Community-based outpatient parenteral antimicrobial therapy (CoPAT) for Staphylococcus aureus bacteraemia with or without infective endocarditis: analysis of the randomized trial comparing daptomycin with standard therapy","volume":"63","author":"Rehm","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ejim.2013.03.014_bb0100","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jinf.2003.10.001","article-title":"Evaluation of outpatient treatment with ertapenem in a double blind controlled clinical trial of complicated skin\/skin structure infections","volume":"48","author":"Gesser","year":"2004","journal-title":"J Infect"},{"key":"10.1016\/j.ejim.2013.03.014_bb0105","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1093\/jac\/dks003","article-title":"Good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults in the UK: a consensus statement","volume":"67","author":"Chapman","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ejim.2013.03.014_bb0110","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/jac\/dkp147","article-title":"Development of teicoplanin dosage guidelines for patients treated within an outpatient parenteral antibiotic therapy (OPAT) programme","volume":"64","author":"Lamont","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ejim.2013.03.014_bb0115","series-title":"Final Report","article-title":"Review of prescribing, supply and administration of medicines","author":"Department of Health","year":"1999"},{"key":"10.1016\/j.ejim.2013.03.014_bb0120","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/jac\/dki092","article-title":"Nurse-led management of uncomplicated cellulitis in the community: evaluation of a protocol incorporating intravenous ceftriaxone","volume":"55","author":"Seaton","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ejim.2013.03.014_bb0125","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/qjmed\/92.11.659","article-title":"Outpatient parenteral antimicrobial therapy\u2014a viable option for the management of cutaneous Leishmaniasis","volume":"92","author":"Seaton","year":"1999","journal-title":"Q J Med"},{"key":"10.1016\/j.ejim.2013.03.014_bb0130","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000048564","article-title":"The management of skin and soft tissue infections: outpatient parenteral antibiotic therapy in the United Kingdom","volume":"47","author":"Nathwani","year":"2001","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ejim.2013.03.014_bb0135","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ijantimicag.2011.05.008","article-title":"Factors associated with outcome and length of parenteral therapy in outpatient parenteral antibiotic therapy (OPAT) treated patients with skin and soft tissue infections","volume":"38","author":"Seaton","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ejim.2013.03.014_bb0140","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1093\/jac\/37.5.1023","article-title":"Safe intravenous therapy at home: experience of a UK based programme","volume":"37","author":"Kayley","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ejim.2013.03.014_bb0150","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/jac\/dkq445","article-title":"Outpatient parenteral antibiotic therapy (OPAT) for bone and joint infections: experience from a UK teaching hospital-based service","volume":"66","author":"Mackintosh","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ejim.2013.03.014_bb0155","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.eimc.2011.05.007","article-title":"Efficacy and safety of outpatient parenteral antibiotic therapy for infective endocarditis: a ten-year prospective study","volume":"29","author":"Cervera","year":"2011","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.ejim.2013.03.014_bb0160","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/dkt046","article-title":"Risk factors for failure of outpatient parenteral antibiotic therapy (OPAT) in infective endocarditis","author":"Duncan","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ejim.2013.03.014_bb0165","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1086\/313503","article-title":"Outpatient parenteral antimicrobial therapy for central nervous system infections","volume":"29","author":"Tice","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ejim.2013.03.014_bb0170","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jinf.2011.11.019","article-title":"Enteric fever in returning travellers: role of outpatient parenteral antibiotic therapy","volume":"64","author":"White","year":"2012","journal-title":"J Infect"},{"key":"10.1016\/j.ejim.2013.03.014_bb0175","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1093\/jac\/dkq152","article-title":"Ertapenem administered as outpatient parenteral antibiotic therapy for urinary tract infections caused by extended-spectrum-beta-lactamase-producing Gram-negative organisms","volume":"65","author":"Bazaz","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ejim.2013.03.014_bb0180","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/jac\/45.2.247","article-title":"Meropenem 3g once daily for outpatient treatment of infective exacerbations of bronchiectasis","volume":"45","author":"Darley","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ejim.2013.03.014_bb0185","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/qjmed\/hcs189","article-title":"Review of suspected Lyme infection management via an outpatient parenteral antimicrobial therapy (OPAT) service","volume":"106","author":"White","year":"2013","journal-title":"Q J Med"},{"key":"10.1016\/j.ejim.2013.03.014_bb0190","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ijantimicag.2011.02.005","article-title":"Development and impact of the Scottish National Antimicrobial Stewardship Programme","volume":"38","author":"Nathwani","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ejim.2013.03.014_bb0195","first-page":"410","article-title":"Outpatient parenteral antimicrobial therapy (OPAT) with ceftriaxone","volume":"34","author":"Duncan","year":"2012","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.ejim.2013.03.014_bb0200","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/j.1742-1241.2008.01824.x","article-title":"Outpatient parenteral antibiotic therapy with daptomycin: insights from a patient registry","volume":"62","author":"Martone","year":"2008","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.ejim.2013.03.014_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2013.01.019","article-title":"Daptomycin for outpatient parenteral antibiotic therapy: a European registry experience","author":"Seaton","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ejim.2013.03.014_bb0210","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ijantimicag.2012.01.016","article-title":"Outpatient parenteral antimicrobial therapy in a teaching hospital based practice: a retrospective cohort study describing experience and evolution over 10years","volume":"39","author":"Barr","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ejim.2013.03.014_bb0215","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0002-9343(98)00362-3","article-title":"Adverse effects of outpatient parenteral antibiotic therapy","volume":"106","author":"Hoffman-Terry","year":"1999","journal-title":"Am J Med"},{"key":"10.1016\/j.ejim.2013.03.014_bb0220","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1007\/s10096-012-1604-z","article-title":"Self-administration of outpatient parenteral antibiotic therapy and risk of catheter-related adverse events: a retrospective cohort study","volume":"31","author":"Barr","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ejim.2013.03.014_bb0225","doi-asserted-by":"crossref","first-page":"22","DOI":"10.52964\/AMJA.0451","article-title":"Delivering outpatient antibiotic therapy (OPAT) in an Acute Medical Unit","volume":"10","author":"Yan","year":"2011","journal-title":"Acute Med"},{"key":"10.1016\/j.ejim.2013.03.014_bb0230","doi-asserted-by":"crossref","first-page":"S220","DOI":"10.1086\/653523","article-title":"H Hospitalist to home: outpatient parenteral antimicrobial therapy at an academic centre","volume":"51","author":"Nguyen","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ejim.2013.03.014_bb0235","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2165\/00003495-200059003-00004","article-title":"Pharmacoeconomic considerations in the ambulatory use of parenteral cephalosporins","volume":"59","author":"Tice","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.ejim.2013.03.014_bb0240","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijantimicag.2008.07.016","article-title":"A cost analysis of Outpatient Parenteral Antibiotic Therapy (OPAT): an Asian perspective","volume":"33","author":"Yong","year":"2009","journal-title":"Int J Antimicrob Agents"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620513000988?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620513000988?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T06:27:12Z","timestamp":1644820032000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620513000988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0953620513000988"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2013.03.014","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outpatient parenteral antibiotic therapy: Principles and practice","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2013.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}